ML290, an Allosteric Relaxin-RXFP1 Agonist, Attenuates Experimental Pulmonary Hypertension Conference

Yang, P, Yung, L, van Deusen, C et al. (2018). ML290, an Allosteric Relaxin-RXFP1 Agonist, Attenuates Experimental Pulmonary Hypertension . American Journal of Respiratory and Critical Care Medicine, 197

Industry Collaboration International Collaboration

cited authors

  • Yang, P; Yung, L; van Deusen, C; Bocobo, G; Dinter, T; Cavallo, J; Chain, D; Dwyer, SC; Southwood, M; Jia, Z; Morrell, NW; Illiano, S; Ferrer, M; Southall, N; Wilson, KJ; Marugan, JJ; Agoulnik, AI; Yu, PB

authors

date/time interval

  • May 18, 2018 -

publication date

  • January 1, 2018

webpage

published in

keywords

  • Critical Care Medicine
  • General & Internal Medicine
  • Life Sciences & Biomedicine
  • Respiratory System
  • Science & Technology

volume

  • 197